3-D Matrix Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3410730000
JPY
422.00
5 (1.2%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

6.99 M

Shareholding (Jan 2026)

FII

0.03%

Held by 1 FIIs

DII

99.97%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Poor Management Efficiency with a low ROCE of 0%

  • The company has reported losses and also has negative networth. This is not a good sign for the investors. Either company will have to raise fresh capital or report profits to sustain going forward
2

High Debt Company with a Debt to Equity ratio (avg) at times

3

With a growth in Net Sales of 42.21%, the company declared Outstanding results in Oct 25

4

With ROE of -37.31%, it has a risky valuation with a 5.96 Price to Book Value

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

JPY 57,702 Million (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.04

stock-summary
Return on Equity

0.76%

stock-summary
Price to Book

14.59

Revenue and Profits:
Net Sales:
2,538 Million
(Quarterly Results - Jan 2026)
Net Profit:
652 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
21.26%
0%
21.26%
6 Months
27.11%
0%
27.11%
1 Year
222.14%
0%
222.14%
2 Years
229.69%
0%
229.69%
3 Years
89.24%
0%
89.24%
4 Years
30.25%
0%
30.25%
5 Years
50.18%
0%
50.18%

3-D Matrix Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
59.69%
EBIT Growth (5y)
9.33%
EBIT to Interest (avg)
-242.52
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.46
Sales to Capital Employed (avg)
1.06
Tax Ratio
0.89%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
5.96
EV to EBIT
-15.36
EV to EBITDA
-15.36
EV to Capital Employed
4.40
EV to Sales
2.55
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-28.64%
ROE (Latest)
-37.31%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jan 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.03%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jan'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jan 2026 is 42.21% vs 55.49% in Jan 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jan 2026 is 210.95% vs -4.83% in Jan 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jan'26",
        "Jan'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,538.40",
          "val2": "1,785.00",
          "chgp": "42.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "346.60",
          "val2": "-74.10",
          "chgp": "567.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.70",
          "val2": "17.90",
          "chgp": "-90.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-8.00",
          "val2": "-5.00",
          "chgp": "-60.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "652.40",
          "val2": "-588.00",
          "chgp": "210.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "136.60%",
          "val2": "-41.50%",
          "chgp": "17.81%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Apr'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Apr 2025 is 51.11% vs 98.30% in Apr 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Apr 2025 is -878.94% vs 89.55% in Apr 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Apr'25",
        "Apr'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6,934.10",
          "val2": "4,588.80",
          "chgp": "51.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1,156.20",
          "val2": "-2,117.00",
          "chgp": "45.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "74.40",
          "val2": "83.80",
          "chgp": "-11.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "4.60",
          "val2": "-164.80",
          "chgp": "102.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2,501.20",
          "val2": "-255.50",
          "chgp": "-878.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-166.70%",
          "val2": "-461.30%",
          "chgp": "29.46%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jan'26 - YoYstock-summary

Jan'26
Jan'25
Change(%)
Net Sales
2,538.40
1,785.00
42.21%
Operating Profit (PBDIT) excl Other Income
346.60
-74.10
567.75%
Interest
1.70
17.90
-90.50%
Exceptional Items
-8.00
-5.00
-60.00%
Consolidate Net Profit
652.40
-588.00
210.95%
Operating Profit Margin (Excl OI)
136.60%
-41.50%
17.81%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jan 2026 is 42.21% vs 55.49% in Jan 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jan 2026 is 210.95% vs -4.83% in Jan 2025

Annual Results Snapshot (Consolidated) - Apr'25stock-summary

Apr'25
Apr'24
Change(%)
Net Sales
6,934.10
4,588.80
51.11%
Operating Profit (PBDIT) excl Other Income
-1,156.20
-2,117.00
45.38%
Interest
74.40
83.80
-11.22%
Exceptional Items
4.60
-164.80
102.79%
Consolidate Net Profit
-2,501.20
-255.50
-878.94%
Operating Profit Margin (Excl OI)
-166.70%
-461.30%
29.46%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Apr 2025 is 51.11% vs 98.30% in Apr 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Apr 2025 is -878.94% vs 89.55% in Apr 2024

stock-summaryCompany CV
About 3-D Matrix Ltd. stock-summary
stock-summary
3-D Matrix Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available